1399 Evaluation Webform

­­­­­­­

Evaluation Form
Novel Oral Anticoagulants:

Transforming Stroke Prevention in Nonvalvular Atrial Fibrillation

We greatly value your opinion. Your responses in this evaluation will be used in future planning of new courses and offerings for members of the healthcare team.

Strongly Agree Agree Neutral Disagree Strongly Disagree
Identify patients with nonvalvular atrial fibrillation who are most likely to benefit from timely initiation of novel oral anticoagulant therapy
Analyze the risks and benefits of current and emerging novel oral anticoagulants for patients with nonvalvular atrial fibrillation at risk for stroke
Discuss emerging novel oral anticoagulants and reversal therapies and their impact on the treatment landscape for nonvalvular atrial fibrillation
Strongly Agree Agree Neutral Disagree Strongly Disagree
The faculty were effective in presenting the material
The content was evidence based
The educational material provided useful information for my practice
The activity provided appropriate and effective opportunities for active learning (e.g., case studies, discussion, Q&A, etc.)
The opportunities provided to assess my own learning were appropriate (e.g., questions before, during or after the activity)